11
2014
-
03
4 Huawu Pharmaceutical production lines obtained GMP certificate
Author：
The four production lines of Huawu Pharmaceutical raw materials (artemether, artesunate, dihydroartemisinin) Maqin cough syrup have passed GMP on-site inspection. On March 11, 2014, it has obtained the drug GMP certificate.
Latest News
2018-11-19
Announcement of the full text of the environmental impact report of the renovation and expansion project
According to the relevant provisions of the "Environmental Impact Assessment Law" and the "Interim Measures for Public Participation in Environmental Impact Assessment".
2018-10-24
The second public announcement of the environmental impact assessment of the reconstruction and expansion project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd.
According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment", the relevant information on the environmental impact assessment of the "Reconstruction and Expansion Project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd." is now announced.
2018-10-08
Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Environmental Impact Assessment Public Participation First Public Announcement
According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment," combined with the characteristics of the construction project
2015-10-06
2015 company employee training
From September 29th to 30th, 2015, the company took pictures after training all employees on safety, GMP, ICQ7, TPM and corporate culture.
2015-01-23
Chongqing Huafang Wulingshan Pharmaceutical Co., Ltd. Enterprise Technology Center
Chongqing Huafang Wulingshan Pharmaceutical Co., Ltd. is recognized as a municipal enterprise technology center